I'm curious too. I want to know if Shseido is obligated to share their research and advancements with Replicel. If not they may have merely procured Replicel's original methodologies (through the partnership) to bootstrap, augment or otherwise support their own research. Making several small investments and partnerships with potential solutions in a space doesn't seem unusual. Anyone privileged to the terms of the contract? I want to believe Shseido is still advancing their own research/techniques.